powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1225425747
Itivrita Goyal
M.D.
Endocrinology
Oklahoma City,
OK
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
1,139
Beneficiaries
—
Total drug cost
$560K
Distinct drugs
22
Brand share
59.7%
Top prescribed drugs
Dulaglutide
157 claims
Levothyroxine Sodium
148 claims
Insulin Glargine,hum.Rec.Anlog
88 claims
Semaglutide
80 claims
Metformin Hcl
74 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 370093
Hospital
CCN 370234
Hospital
QUALITY · MIPS · 2024
Final MIPS score
77.3
Quality
53.7
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.10%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
369
Unique beneficiaries
—
Total services
590
Distinct HCPCS
8
Medicare payment
$36K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 45 Endocrinology providers in OK — above median (cohort median 861).
